EADV: Ascletis/Sagimet’s Acne Drug Shows Rapid Efficacy In China Phase III Trial

 
• By Dexter Jie Yan
  
Denifanstat could offer a new therapy for moderate-to-severe acne vulgaris in China. (Shutterstock)

More from Clinical Trials

More from R&D